Together we will beat cancer

Donate
Blank Avatar

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.

Lung cancer screening part 2: research into detection technology could lead to better tests

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

Read More

Lung cancer screening part 1: the benefits and harms according to clinical trials

Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.

Read More

Could Mother Nature’s clinical trial help prevent more cancers?

By studying small differences in our DNA, called SNPs, our scientists are showing how these could be used to help prevent cancer in the future.

Read More

Alternative cancer therapies: the potential impact on survival

Research from the US provides evidence of the harm of patients choosing alternative therapy and declining conventional treatments and the impact on survival.

Read More

Professor Jack Cuzick: ‘Sitting on the borders between maths and cancer medicine’

Professor Jack Cuzick has received our Lifetime Achievement Award for his work on cancer prevention and detection.

Read More

Sugar and cancer – what you need to know

We tackle the myth that sugar ‘feeds’ cancer cells, and explore how the amount of sugar in our diets is cause for concern due to obesity.

Read More

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

Read More

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

Read More

Taking advantage of cancers’ abnormal metabolism could lead to a new way to ‘starve’ tumours

Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.

Read More

Giving pancreatic cancer patients better opportunities to join clinical trials

We’re backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.

Read More